JLE

Epileptic Disorders

MENU

PET imaging in epilepsy: basal ganglia and thalamic involvement Volume 4, supplement 3, Supplement 3, December 2002

1. Deransart C, Vercueil L, Marescaux C, Depaulis A. The role of basal ganglia in the control of generalized absence seizures. Epilepsy Res 1998; 32: 213-23.

2. Rektor I, Kuba R, Brazdil M. Interictal and ictal EEG activity in the basal ganglia: an SEEG study in patients with temporal lobe epilepsy. Epilepsia 2002; 43: 253-62.

3. Newton MR, Berkovic SF, Austin MC, et al. Dystonia, clinical lateralization, and regional blood flow changes in temporal lobe seizures. Neurology 1992; 42: 371-7.

4. Henry TR, Mazziotta JC, Engel J Jr., et al. Quantifying interictal metabolic activity in human temporal lobe epilepsy. J Cereb Blood Flow Metab 1990; 10: 748-57.

5. Arnold S, Schlaug G, Niemann H, et al. Topography of interictal glucose hypometabolism in unilateral mesiotemporal epilepsy. Neurology 1996; 46: 1422-430.

6. DeCarli C, Hatta J, Fazilat S, et al. Extratemporal atrophy in patients with complex partial seizures of left temporal origin. Ann Neurol 1998; 43: 41-5.

7. Deasy NP, Jarosz JM, Elwes RC, Polkey CE, Cox TC. Thalamic changes with mesial temporal sclerosis: MRI. Neuroradiology 2000; 42: 346-51.

8. Dreifuss S, Vingerhoets FJ, Lazeyras F, et al. Volumetric measurements of subcortical nuclei in patients with temporal lobe epilepsy. Neurology 2001; 57: 1636-41.

9. Khan N, Leenders KL, Hajek M, et al. Thalamic glucose metabolism in temporal lobe epilepsy measured with 18F-FDG positron emission tomography (PET). Epilepsy Res 1997; 28: 233-43.

10. Swartz BE, Khonsari A, Brown C, et al. Improved sensitivity of 18FDG-positron emission tomography scans in frontal and Òfrontal plusÓ epilepsy. Epilepsia 1995; 36: 388-95.

11. Dupont S, Semah F, Samson Y, Baulac M. The underlying pathophysiology of ictal dystonia in temporal lobe epilepsy: an FDG-positron emission tomography study. Neurology 1998; 51: 1289-92.

12. Kotagal P, LŸders HO, Morris HH, et al. Dystonic posturing in complex partial seizures of temporal lobe onset: a new lateralizing sign. Neurology 1989; 39: 196-201.

13. Dupont S, Semah F, Boon PA, et al. Association of ipsilateral motor automatisms and contralateral dystonic posturing: a clinical feature differentiating medial temporal lobe epilepsy from neocortical temporal lobe epilepsy. Arch Neurol 1999; 56: 927-32.

14. Theodore WH, Brooks R, Margolin R, et al. Positron emission tomography in generalized seizures. Neurology 1985; 35: 684-90.

15. Swartz BE, Simpkins F, Halgren E, et al. Visual working memory in primary generalized epilepsy: an 18FDG-PET study. Neurology 1996; 47: 1203-12.

16. Mazière M, Hantraye P, Prenant C, Sastre J, Comar D. Synthesis of ethyl 8-fluoro-5.6-dihydro-5-(11C)methyl-6-oxo-4Himidazol( 1.5-a) benzodiazepine-3-carboxylate (Ro 15-1788): a specific radioligand for in vivo study of central benzodiazepine receptors by positron emission tomography. Int J Appl Radiat Isotop 1984; 35: 973-8.

17. Burdette DE, Sakurai SY, Henry TR, et al. Temporal lobe central benzodiazepine binding in unilateral mesial temporal lobe epilepsy. Neurology 1995; 45: 934-41.

18. Koepp MJ, Richardson MP, LabbéC, et al. 11C-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy. Neurology 1997; 49: 764-73.

19. Ryvlin P, Bouvard S, Le Bars D, Mauguiere F. Transient and falsely lateralizing flumazenil-PET asymmetries in temporal lobe epilepsy. Neurology 1999; 53: 1882-5.

20. Ryvlin P, Bouvard S, Le Bars D, et al. Clinical utility of flumazenil- PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study of 100 patients. Brain 1998; 121: 2067-81.

21. Koepp MJ, Hammers A, Labbe C, et al. 11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI. Neurology 2000; 54: 332-9.

22. Bouilleret V, Dupont S, Spelle L, et al. Insular cortex involvement in mesiotemporal lobe epilepsy: a positron emission tomography study. Ann Neurol 2002; 51: 202-8.

23. Prevett MC, Lammertsma AA, Brooks DJ, et al. Benzodiazepine- GABAA receptors in idiopathic generalized epilepsy measured with [11C]flumazenil and positron emission tomography. Epilepsia 1995; 36: 113-21.

24. Koepp MJ, Richardson MP, Brooks DJ, Cunningham VJ, Duncan JS. Central benzodiazepine/gamma-aminobutyric acid A receptors in idiopathic generalized epilepsy: an [11C]flumazenil positron emission tomography study. Epilepsia 1997; 38: 1089-97.

25. Savic I, Pauli S, Thorell JO, Blomqvist G. In vivo demonstration of altered benzodiazepine receptor density in patients with generalised epilepsy. J Neurol Neurosurg Psychiatry 1994; 57: 797-804.

26. Lamprecht F. Epilepsy and schizophrenia: a neurochemical bridge. J Neural Transm 1977; 40: 159-70.

27. Starr MS. The role of dopamine in epilepsy. Synapse 1996; 22: 159-94.

28. Ring HA, Trimble MR, Costa DC, et al. Striatal dopamine receptor binding in epileptic psychoses. Biol Psychiatry 1994; 35: 375-80.

29. Biraben A, Semah F, Ribeiro MJ, et al. Decreased striatal dopamine uptake in patients with epileptic seizures associated with ring chromosome 20 mosaicism. Epilepsia 2001; 42 (suppl 2): 175.